… unmixed, not put up in measured doses or in forms or packings for retail sale …
INN
… … efpeglenatide … eftilagimod alfa … eftozanermin alfa … efungumab … eldelumab … elezanumab … elgemtumab … elipovimab … … omodenbamab … onartuzumab … onercept … onfekafusp alfa … ongericimab … ontamalimab … ontorpacept … ontuxizumab … … telpegfilgrastim … temelimab … tenatumomab … teneliximab … tengonermin … teplizumab … tepoditamab … teprotumumab … …Classification opinions
… modulates immune functions. Application of GIRs 1 and 6 (Subheading Note 1 (a) to Chapter 30). Adoption : 1995 … 2. … part may be indicated in the product name (INN) by adding a number, for example : peginterferon alfa-2a (40 … hepatitis B or hepatitis C. Application of GIRs 1 and 6 (Subheading Note 1 (a) to Chapter 30). Adoption : 2009 … 3. …